Advisory Research’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Advisory Research’s Portfolio PIIIW Stock Details PIIIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-65,835	Closed	-$5.27K	–	475
2023 Q1	$5.27K	Hold	65,835	–	–	﹤0.01%	345
2022 Q4	$9.22K	Hold	65,835	–	–	﹤0.01%	357
2022 Q3	$49K	Sell	65,835 -1,517	-2%	-$1.09K	﹤0.01%	329
2022 Q2	$34K	Sell	67,352 -30,348	-31%	-$35.8K	﹤0.01%	329
2022 Q1	$155K	Hold	97,700	–	–	0.01%	347
2021 Q4	$103K	Buy	+97,700	New	+$118K	0.01%	317

Other funds holding PIIIW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Advisory Research's PIIIW Position: Q2 2023 in Review

Advisory Research sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 65,835 shares — an estimated $5.27K sold.

Advisory Research first reported a position in PIIIW in Q4 2021 and held it in 6 quarters. The position peaked at $155K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

Advisory Research reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
Advisory Research sold 65,835 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $5.27K.
Advisory Research first reported a position in P3 Health Partners Inc Warrant in Q4 2021 and held it in 6 quarters.
Advisory Research's P3 Health Partners Inc Warrant position peaked at $155K in Q1 2022.
22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.